WAY, US9467841055

Waystar schedules November 2 results. Waystar stock stands at EUR 24.10

Published on 10/15/2026 at 13:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 revenue reached USD 319.67 million, up 18.10 percent year over year. November 2, 2026 is the next results date, while 24 analysts cover Waystar stock.

Results date and earnings profile

  • Waystar announced third-quarter results for November 2, 2026.
  • Second-quarter revenue reached USD 319.67 million, up 18.10 percent year over year.
  • Waystar stock traded at EUR 24.10 at 1:39 p.m. CEST at Lang & Schwarz on October 15, 2026.
  • Twenty-four analysts covered the company with an average target of USD 34.67 on October 5, 2026.
WAY, US9467841055, Illustration mit AI erstellt.
WAY, US9467841055, Illustration mit AI erstellt.

Waystar Holding Corp. (ISIN US9467841055) scheduled its third-quarter 2026 results for November 2, 2026, while Waystar stock traded at EUR 24.10 at Lang & Schwarz on October 15, 2026 at 1:39 p.m. CEST. The company said the quarter ended September 30, 2026, and that its conference call will begin at 4:30 p.m. Eastern Time. Waystar published the schedule on October 14, 2026.

November 2 sets the next test

The November report will be the next quantified check on a business that delivered USD 319.67 million in second-quarter revenue ended June 30, 2026. Revenue increased 18.10 percent from the year-earlier quarter, while consolidated net income reached USD 40.87 million and diluted earnings per share were USD 0.21.

The company serves more than 30,000 clients and processes more than 7.5 billion healthcare payment transactions annually. Its platform covers over USD 2.4 trillion in annual gross claims, according to Waystar.

What does the earnings base show?

Waystar's recent operating record provides the clearest comparison. On July 29, 2026, the company reported second-quarter revenue of USD 319.67 million and net income of USD 40.87 million, figures that Business Quant lists from company filings. The revenue increase was 18.10 percent year over year, giving investors a concrete benchmark for the September quarter.

Three recent dates and figures

On July 29, 2026, Waystar reported USD 319.67 million in second-quarter revenue. On October 6, 2026, Chief Executive Matthew Hawkins sold 82,500 shares at an average USD 26.23 under a pre-arranged trading plan, as MarketBeat reported on October 7, 2026. On October 14, 2026, Waystar announced the November 2 results date.

Dates for the earnings calendar

November 2, 2026 is the next reporting date, and the conference call is scheduled for 4:30 p.m. Eastern Time. The release will cover the third quarter ended September 30, 2026, giving the market a fresh period against which to measure revenue growth and profitability.

Stock valuation remains the market context

MarketBeat reported on October 5, 2026 that 24 analysts covered Waystar, with an average 12-month price target of USD 34.67. The same report cited a consensus Moderate Buy rating, while the stock's latest quarterly comparison remained the USD 319.67 million revenue figure from the June quarter.

Waystar stock was trading at EUR 24.10 at Lang & Schwarz on October 15, 2026 at 1:39 p.m. CEST. The company had a market capitalization of USD 5.2 billion as of October 14, 2026, and its Nasdaq-listed shares had a 52-week range of USD 17.26 to USD 40.35. The further course of trading is shown by the continuously updated real-time quote of Waystar stock.

Waystar stock facts

  • Company: Waystar Holding Corp.
  • ISIN: US9467841055
  • Ticker: WAY
  • Primary exchange: Nasdaq
  • Price Lang & Schwarz (as of October 15, 2026, 1:39 p.m. CEST): EUR 24.10
  • Market capitalization: USD 5.2 billion (as of October 14, 2026)
  • 52-week range: USD 17.26-40.35 (as of October 7, 2026)
  • Sector / Industry: Healthcare / Medical - Healthcare Information Services

Market context: Market report S&P 500.

More news and analyses on Waystar stock

Disclaimer...

en | US9467841055 | WAY | boerse | 70329771 | bgmi